How to buy Aeterna Zentaris stock | $0.36

Aeterna Zentaris Inc is a biotechnology business based in the US. Aeterna Zentaris shares (AEZS) are listed on the NASDAQ and all prices are listed in US Dollars.

How to buy shares in Aeterna Zentaris

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for Aeterna Zentaris. Find the stock by name or ticker symbol: AEZS. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Aeterna Zentaris reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At last close price of USD$0.36, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Aeterna Zentaris, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of Aeterna Zentaris. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Aeterna Zentaris share price

Use our graph to track the performance of AEZS stocks over time.

Aeterna Zentaris shares at a glance

• Key figures

Information last updated 2020-12-27.

Latest market close	USD$0.36
52-week range	USD$0.29 - USD$1.38
50-day moving average	USD$0.3785
200-day moving average	USD$0.4681
Wall St. target price	USD$4.5
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$-0.748

Buy Aeterna Zentaris shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Is it a good time to buy Aeterna Zentaris stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Aeterna Zentaris Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Aeterna Zentaris price performance over time

Historical closes compared with the close of $0.36 from 2020-10-19

1 week (2021-01-15)	-43.75%
1 month (2020-12-23)	-12.20%
3 months (2020-10-23)	0.81%
6 months (2020-07-23)	-26.53%

1 year (2020-01-23)	-72.93%
2 years (2019-01-23)	-89.63%
3 years (2018-01-23)	2.4
5 years (2016-01-22)	3.06

Aeterna Zentaris financials

Revenue TTM	USD$1.3 million
Gross profit TTM	USD$122,000
Return on assets TTM	-16.18%
Return on equity TTM	-74.3%
Profit margin	0%
Book value	$0.242
Market capitalisation	USD$24.3 million

TTM: trailing 12 months

Shorting Aeterna Zentaris shares

There are currently 1.9 million Aeterna Zentaris shares held short by investors – that's known as Aeterna Zentaris's "short interest". This figure is 28.1% up from 1.5 million last month.

There are a few different ways that this level of interest in shorting Aeterna Zentaris shares can be evaluated.

Aeterna Zentaris's "short interest ratio" (SIR)

Aeterna Zentaris's "short interest ratio" (SIR) is the quantity of Aeterna Zentaris shares currently shorted divided by the average quantity of Aeterna Zentaris shares traded daily (recently around 3.8 million). Aeterna Zentaris's SIR currently stands at 0.5. In other words for every 100,000 Aeterna Zentaris shares traded daily on the market, roughly 500 shares are currently held short.

However Aeterna Zentaris's short interest can also be evaluated against the total number of Aeterna Zentaris shares, or, against the total number of tradable Aeterna Zentaris shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Aeterna Zentaris's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Aeterna Zentaris shares in existence, roughly 30 shares are currently held short) or 0.0301% of the tradable shares (for every 100,000 tradable Aeterna Zentaris shares, roughly 30 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Aeterna Zentaris.

Find out more about how you can short Aeterna Zentaris stock.

Aeterna Zentaris share dividends

We're not expecting Aeterna Zentaris to pay a dividend over the next 12 months.

Have Aeterna Zentaris's shares ever split?

Aeterna Zentaris's shares were split on a 1:100 basis on 20 November 2015. So if you had owned 100 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Aeterna Zentaris shares – just the quantity. However, indirectly, the new 9900% higher share price could have impacted the market appetite for Aeterna Zentaris shares which in turn could have impacted Aeterna Zentaris's share price.

Aeterna Zentaris share price volatility

Over the last 12 months, Aeterna Zentaris's shares have ranged in value from as little as $0.29 up to $1.38. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aeterna Zentaris's is 2.4425. This would suggest that Aeterna Zentaris's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Aeterna Zentaris overview

Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing pharmaceutical therapies for treating oncology and endocrinology. Its commercial product is the Macrilen, a ghrelin receptor agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a, a ghrelin receptor, which is used for endocrinology and oncology indications. The company has a license and assignment agreement with Strongbridge Ireland Limited for the development, manufacturing, registration, and commercialization of Macrilen in the United States and Canada. Aeterna Zentaris Inc. was incorporated in 1990 and is headquartered in Summerville, South Carolina.

Frequently asked questions

• What percentage of Aeterna Zentaris is owned by insiders or institutions?

  Currently 6.292% of Aeterna Zentaris shares are held by insiders and 4.439% by institutions.

• When does the fiscal year end for Aeterna Zentaris?

  Aeterna Zentaris's fiscal year ends in December.

• Where is Aeterna Zentaris based?

  Aeterna Zentaris's address is: 315 Sigma Drive, Summerville, SC, United States, 29486

• What is Aeterna Zentaris's ISIN number?

  Aeterna Zentaris's international securities identification number is: CA0079754028

• What is Aeterna Zentaris's CUSIP number?

  Aeterna Zentaris's Committee on Uniform Securities Identification Procedures number is: 007975105